| Zhou, Li zhong |
NCT06006689: Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis) |
|
|
| Recruiting | 2 | 228 | RoW | Qishen Yiqi Dripping Pills placebo 3 bags, Placebo group, Low dose Qishen Yiqi Dripping Pills 3 bags, Low dose group, High dose Qishen Yiqi Dripping Pills 3 bags, High dose group | Tasly Pharmaceutical Group Co., Ltd | Diabetic Kidney Disease | 09/25 | 09/25 | | |
NCT06672263: A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia |
|
|
| Not yet recruiting | 1 | 120 | RoW | TQB3911 tablets | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Chronic Myelogenous Leukemia | 09/26 | 12/26 | | |
NCT05606848: To Test the Food for Special Medical Purpose in Perioperative Patients With Gastrointestinal Cancer |
|
|
| Recruiting | N/A | 350 | RoW | Nutrition Emulsion (TPF-T), Foods for special medical purposes [FSMP] for patients with tumors | Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd | Gastrointestinal Cancer | 03/25 | 03/25 | | |
NCT05774288: Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders. |
|
|
| Recruiting | N/A | 244 | RoW | Cera™ patent foramen ovale occluders, Another patent foramen ovale occluders | Lifetech Scientific (Shenzhen) Co., Ltd. | Patent Foramen Ovale, Cryptogenic Stroke | 04/25 | 06/29 | | |
| Liang, Zhiqing |
| Recruiting | 1/2 | 380 | RoW | PM8002 | Biotheus Inc. | Malignant Neoplasm | 11/25 | 11/25 | | |
